TY - JOUR
T1 - KMR
T2 - Knowledge-oriented medicine representation learning for drug–drug interaction and similarity computation
AU - Shen, Ying
AU - Yuan, Kaiqi
AU - Yang, Min
AU - Tang, Buzhou
AU - Li, Yaliang
AU - Du, Nan
AU - Lei, Kai
N1 - Publisher Copyright:
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PY - 2019
Y1 - 2019
N2 - Efficient representations of drugs provide important support for healthcare analytics, such as drug–drug interaction (DDI) prediction and drug–drug similarity (DDS) computation. However, incomplete annotated data and drug feature sparseness create substantial barriers for drug representation learning, making it difficult to accurately identify new drug properties prior to public release. To alleviate these deficiencies, we propose KMR, a knowledge-oriented feature-driven method which can learn drug related knowledge with an accurate representation. We conduct series of experiments on real-world medical datasets to demonstrate that KMR is capable of drug representation learning. KMR can support to discover meaningful DDI with an accuracy rate of 92.19%, demonstrating that techniques developed in KMR significantly improve the prediction quality for new drugs not seen at training. Experimental results also indicate that KMR can identify DDS with an accuracy rate of 88.7% by facilitating drug knowledge, outperforming existing state-of-the-art drug similarity measures.
AB - Efficient representations of drugs provide important support for healthcare analytics, such as drug–drug interaction (DDI) prediction and drug–drug similarity (DDS) computation. However, incomplete annotated data and drug feature sparseness create substantial barriers for drug representation learning, making it difficult to accurately identify new drug properties prior to public release. To alleviate these deficiencies, we propose KMR, a knowledge-oriented feature-driven method which can learn drug related knowledge with an accurate representation. We conduct series of experiments on real-world medical datasets to demonstrate that KMR is capable of drug representation learning. KMR can support to discover meaningful DDI with an accuracy rate of 92.19%, demonstrating that techniques developed in KMR significantly improve the prediction quality for new drugs not seen at training. Experimental results also indicate that KMR can identify DDS with an accuracy rate of 88.7% by facilitating drug knowledge, outperforming existing state-of-the-art drug similarity measures.
KW - Drug embeddings
KW - Drug–drug interaction
KW - Drug–drug similarity
KW - Feature processing
KW - Knowledge representation
UR - https://www.scopus.com/pages/publications/85072835484
U2 - 10.1186/s13321-019-0342-y
DO - 10.1186/s13321-019-0342-y
M3 - 文章
AN - SCOPUS:85072835484
SN - 1758-2946
VL - 11
JO - Journal of Cheminformatics
JF - Journal of Cheminformatics
IS - 1
M1 - 22
ER -